Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-496-1 | CAS number: 121-73-3
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Data is from peer reviewed article or handbook
Data source
Reference
- Reference Type:
- review article or handbook
- Title:
- SCREENING-LEVEL HAZARD CHARACTERIZATION Chloronitrobenzenes Category
- Author:
- U.S. Environmental Protection Agency
- Year:
- 2 012
- Bibliographic source:
- U.S. Environmental Protection Agency Hazard Characterization Document
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- Acute oral toxicity study was conducted to test the effects of m-chlorobenzene on rats and animals were observed for 14 days .Based on mortality the LD50 was determined.
- GLP compliance:
- not specified
- Test type:
- other: No data
- Limit test:
- no
Test material
- Reference substance name:
- 1-chloro-3-nitrobenzene
- EC Number:
- 204-496-1
- EC Name:
- 1-chloro-3-nitrobenzene
- Cas Number:
- 121-73-3
- Molecular formula:
- C6H4ClNO2
- IUPAC Name:
- 1-chloro-3-nitrobenzene
- Details on test material:
- - Name of test material (as cited in study report): 1-chloro-3-nitrobenzene
- Molecular formula (if other than submission substance): C6H4ClNO2
- Molecular weight (if other than submission substance): 165.191 g/mol
- Substance type: Solid
- Physical state: Organic
- Impurities (identity and concentrations): No data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- not specified
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- 14 days
- Doses:
- 0, 200, 251, 316, 398 or 501 mg/kg
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- not specified
- Details on study design:
- No data available
- Statistics:
- No data available
Results and discussion
Effect levels
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 400 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Mortalities were observed at 251, 316, 398 and 501 mg/kg.
- Mortality:
- Mortalities were observed at 251, 316, 398 and 501 mg/kg.
- Clinical signs:
- other: No data available
- Gross pathology:
- No data available
- Other findings:
- No data available
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LD50 was found to be 400mg/kg.
Test substance may be classified as acute toxicity catagory-4. - Executive summary:
Acute study is conducted to study the effect of the test substance onSprague-Dawley rats administered through gavage. The dose concentrations used were 0, 200, 251, 316, 398 or 501 mg/kg. Mortality was observed at 251, 316, 398 and 501 mg/kg.
The LD50was found to be 400mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
